World's Best Scientists 2026 revealed!
Patrick Vermersch

Patrick Vermersch

D-Index & Metrics

Medicine

D-Index
78
Citations
26794
World Ranking
17909
National Ranking
596

Overview

Patrick Vermersch is affiliated with the University of Lille in France, specializing primarily in the field of Medicine. Their research contributions encompass several subfields including Pathology and Forensic Medicine, Neurology, Oncology, Rheumatology, and Genetics.

The scientist's work addresses a range of medical topics with notable focus on multiple sclerosis and related neurological conditions. Key areas of research include:

  • Multiple Sclerosis Research Studies
  • Polyomavirus and related diseases
  • Chronic Lymphocytic Leukemia Research
  • Peripheral Neuropathies and Disorders
  • Systemic Sclerosis and Related Diseases
  • Systemic Lupus Erythematosus Research
  • Acute Lymphoblastic Leukemia research

Patrick Vermersch has contributed to numerous papers, several of which are notable for their publication outcomes and citation impact. Recent significant publications include:

  • Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial (2021) published in The Lancet Neurology
  • The radiologically isolated syndrome: revised diagnostic criteria (2023) published in Brain
  • Optical coherence tomography in multiple sclerosis: A 3-year prospective multicenter study (2021) published in Annals of Clinical and Translational Neurology
  • Masitinib for mild-to-moderate Alzheimer's disease: results from a randomized, placebo-controlled, phase 3, clinical trial (2023) published in Alzheimer s Research & Therapy
  • Siponimod and Cognition in Secondary Progressive Multiple Sclerosis (2021) published in Neurology

The scientist frequently collaborates with several other researchers, some of whom appear consistently as coauthors in their publications. Frequent collaborators include:

  • Gavin Giovannoni
  • Xavier Montalbán
  • de Sèze
  • Heinz Wiendl
  • Celia Oreja-Guevara

Patrick Vermersch's research is disseminated through several key academic journals and publication venues. These are:

  • Neurology
  • Revue Neurologique
  • Multiple Sclerosis and Related Disorders
  • Multiple Sclerosis Journal
  • Neurology and Therapy

Best Publications

  • Atrophy of medial temporal lobes on MRI in “probable” Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates

    P Scheltens;D Leys;F Barkhof;D Huglo

  • A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging

    P. Scheltens;F. Barkhof;D. Leys;J.P Pruvo

  • A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis.

    Gavin Giovannoni;Giancarlo Comi;Stuart Cook;Kottil Rammohan

  • The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer’s disease

    A. Delacourte;J.P. David;N. Sergeant;L. Buée

  • Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

    James F Howard;Kimiaki Utsugisawa;Michael Benatar;Hiroyuki Murai

  • Neuromyelitis optica and non organ-specific autoimmunity.

    Sean J. Pittock;Vanda A. Lennon;Jerome de Seze;Patrick Vermersch

  • Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients.

    Sophie Delalande;Jérôme de Seze;Anne-Laure Fauchais;Eric Hachulla

  • Systemic vascular smooth muscle cell impairment in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.

    Marie Magdeleine Ruchoux;Djelloul Guerouaou;Benedicte Vandenhaute;Jean-Pierre Pruvo

  • Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial:

    Patrick Vermersch;Anna Czlonkowska;Luigi M E Grimaldi;Christian Confavreux

  • Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study

    Elena H. Martinez-Lapiscina;Sam Arnow;James A. Wilson;Shiv Saidha

  • Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1

    Nicolas Sergeant;Bernard Sablonnière;Suzanna Schraen-Maschke;Antoine Ghestem

  • Safety and efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study.

    Gavin Giovannoni;Per Soelberg Sorensen;Stuart Cook;Kottil Rammohan

  • Radiologically Isolated Syndrome: 5-Year Risk for an Initial Clinical Event

    Darin T. Okuda;Aksel Siva;Orhun Kantarci;Matilde Inglese

  • Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria

    S. Schippling;L. J. Balk;F. Costello;P. Albrecht

  • Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis

    Gavin Giovannoni;Stuart Cook;Kottil Rammohan;Peter Rieckmann

  • Immunosuppressive therapy is more effective than interferon in neuromyelitis optica

    C Papeix;J-S Vidal;J de Seze;C Pierrot-Deseilligny

  • Neuromyelitis optica in France A multicenter study of 125 patients

    N. Collongues;R. Marignier;H. Zéphir;C. Papeix

  • Acute myelopathies: Clinical, laboratory and outcome profiles in 79 cases.

    Jérôme de Seze;Tanya Stojkovic;Guillaume Breteau;Christian Lucas

  • Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial

    Thomas P. Leist;Giancarlo Comi;Bruce A C Cree;Patricia K. Coyle

  • Devic's neuromyelitis optica: clinical, laboratory, MRI and outcome profile

    J. de Seze;T. Stojkovic;D. Ferriby;J.-Y. Gauvrit

Frequent Co-Authors

Gavin Giovannoni
Gavin Giovannoni Queen Mary University of London
Giancarlo Comi
Giancarlo Comi Vita-Salute San Raffaele University
Per Soelberg Sørensen
Per Soelberg Sørensen University of Copenhagen
Bruce A. C. Cree
Bruce A. C. Cree University of California, San Francisco
Ludwig Kappos
Ludwig Kappos University Hospital of Basel
Ralf Gold
Ralf Gold Ruhr University Bochum
Xavier Montalban
Xavier Montalban Autonomous University of Barcelona
Amit Bar-Or
Amit Bar-Or University of Pennsylvania
Frédéric Blanc
Frédéric Blanc University of Strasbourg
Heinz Wiendl
Heinz Wiendl University of Münster

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering medical studies in the USA, there are various online programs that offer flexible, rewarding career paths in healthcare. For those interested in nursing, numerous nursing school that doesn't require teas provide an accessible route without the stress of additional entrance exams.

Looking to move into healthcare administration? Earning a healthcare administration associate degree online can open doors to management positions in hospitals, clinics, and insurance companies. For registered nurses wanting to advance, many opt for adn to fnp bridge programs, which enable a smooth transition from an Associate Degree in Nursing to becoming a Family Nurse Practitioner.

If nutrition and wellness are your passion, consider an online dietitian degree for a path in dietary science and public health. These online programs offer flexibility, allowing you to study at your own pace while gaining the skills needed for thriving healthcare careers.

Best Scientists Citing Patrick Vermersch

Trending Scientists

Recently Published Articles